Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In this trial, patients with SIDD or SIRD characteristics were randomly assigned to receive semaglutide, a glucagon-like peptide 1 receptor agonist (GLP1ra), or dapagliflozin, a sodiumglucose cotransporter 2 inhibitor (SGLT2i)
CrossRef Multi-omics integration reveals ANXA6-high T cellendothelial communication as a potential link between periodontitis and MASLD Zhongxuan Zhang, Zihan Ma, Ruidong Zhang, Min Ye, Zhongyu Shi, Miao Yu, Lingling Ou npj Systems Biology and Applications .2026;[Epub] CrossRef Creatinine clearance rate predicts all-cause and cardiovascular mortality in patients with MASLD: a Shanghai cohort study Yingqi Hou, Yanqiu Huang, Chenghao Zhang, Wen Gu, Yadan Xu, Shuli Li, Jugang Wu, Jibin Liu, Honglin Liu Frontiers in Medicine .2026;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease and acute leukemias a literature review and future directions Tareq Salah, Maximillian Stahl, Jan Philipp Bewersdorf Leukemia & Lymphoma .2026
Fine-dispersed - the henna dissolves to the necessary consistency in seconds
Shan, C
US$ 23.43
US$ 29.31
US$ 25.87
US$ 23.11
US$ 20.57
US$ 26.25
US$ 28.23
